162 related articles for article (PubMed ID: 15905296)
1. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.
Ibáñez L; Jaramillo AM; Ferrer A; de Zegher F
Hum Reprod; 2005 Sep; 20(9):2457-62. PubMed ID: 15905296
[TBL] [Abstract][Full Text] [Related]
2. Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio.
Ibáñez L; Valls C; de Zegher F
Hum Reprod; 2006 Feb; 21(2):451-6. PubMed ID: 16239318
[TBL] [Abstract][Full Text] [Related]
3. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
Ibáñez L; De Zegher F
Hum Reprod; 2004 Aug; 19(8):1725-7. PubMed ID: 15229206
[TBL] [Abstract][Full Text] [Related]
4. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
Ibáñez L; de Zegher F
Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
[TBL] [Abstract][Full Text] [Related]
5. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
Ibáñez L; de Zegher F
Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
[TBL] [Abstract][Full Text] [Related]
6. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
Ibáñez L; De Zegher F
J Clin Endocrinol Metab; 2003 Oct; 88(10):4720-4. PubMed ID: 14557446
[TBL] [Abstract][Full Text] [Related]
7. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
8. Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome.
Ibáñez L; de Zegher F
Hum Reprod; 2003 Jan; 18(1):57-60. PubMed ID: 12525441
[TBL] [Abstract][Full Text] [Related]
9. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
[TBL] [Abstract][Full Text] [Related]
10. Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess.
Ibáñez L; Díaz M; López-Bermejo A; de Zegher F
Gynecol Endocrinol; 2011 Mar; 27(3):197-8. PubMed ID: 20528210
[TBL] [Abstract][Full Text] [Related]
11. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
Ibáñez L; Valls C; Ferrer A; Ong K; Dunger DB; De Zegher F
J Clin Endocrinol Metab; 2002 Jun; 87(6):2870-4. PubMed ID: 12050266
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess.
Lázaro I; Díaz M; Cabré A; Masana L; Ibáñez L
Gynecol Endocrinol; 2011 Nov; 27(11):935-9. PubMed ID: 21605000
[TBL] [Abstract][Full Text] [Related]
13. Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome.
Hadžiomerović-Pekić D; Wildt L; Weiss JM; Moeller K; Mattle V; Seeber BE
Fertil Steril; 2010 Nov; 94(6):2385-8. PubMed ID: 20356587
[TBL] [Abstract][Full Text] [Related]
14. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.
Ibáñez L; López-Bermejo A; Díaz M; Enríquez G; del Río L; de Zegher F
Clin Endocrinol (Oxf); 2009 Sep; 71(3):351-7. PubMed ID: 19018783
[TBL] [Abstract][Full Text] [Related]
15. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.
Ibáñez L; López-Bermejo A; del Rio L; Enríquez G; Valls C; de Zegher F
J Clin Endocrinol Metab; 2007 May; 92(5):1710-4. PubMed ID: 17299064
[TBL] [Abstract][Full Text] [Related]
16. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.
Ibáñez L; Jaramillo A; Ferrer A; de Zegher F
Hum Reprod; 2005 Jul; 20(7):1833-6. PubMed ID: 15802316
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin.
Ibáñez L; López-Bermejo A; Díaz M; Enríquez G; Valls C; de Zegher F
Clin Endocrinol (Oxf); 2008 Feb; 68(2):317-20. PubMed ID: 18031315
[TBL] [Abstract][Full Text] [Related]
18. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
Ibáñez L; Valls C; Cabré S; De Zegher F
J Clin Endocrinol Metab; 2004 Sep; 89(9):4716-20. PubMed ID: 15356085
[TBL] [Abstract][Full Text] [Related]
19. [Low-dose flutamide in the treatment of hyperandrogenism in adolescents].
Pizzo A; Borrielli I; Mastroeni MT; Fattori A; Dugo C; Dugo N; Dinatale A
Minerva Pediatr; 2008 Dec; 60(6):1357-66. PubMed ID: 18971896
[TBL] [Abstract][Full Text] [Related]
20. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
